Incidence Rates Table
State
|
Met Healthy People Objective of ***? |
Age-Adjusted Incidence Rate† cases per 100,000 (95% Confidence Interval) 
|
CI*Rank⋔ (95% Confidence Interval) 
|
Average Annual Count
|
Recent Trend |
Recent 5-Year Trend‡ in Incidence Rates (95% Confidence Interval)
|
|---|---|---|---|---|---|---|
| US (SEER+NPCR) 1 | *** | 125.1 (124.6, 125.6) | N/A | 250,518 |
rising 
|
0.3 (0.1, 0.5) |
| District of Columbia 2 | *** | 145.9 (133.3, 159.4) | 1 (1, 28) | 519 |
stable 
|
-0.5 (-1.7, 0.8) |
| Hawaii 7 | *** | 144.3 (136.1, 152.8) | 2 (1, 20) | 1,285 |
rising
|
1.8 (0.9, 2.7) |
| New Jersey 7 | *** | 138.4 (135.2, 141.5) | 3 (1, 15) | 7,890 |
rising
|
0.5 (0.2, 0.7) |
| Minnesota 2 | *** | 138.3 (134.2, 142.5) | 4 (1, 19) | 4,639 |
stable
|
0.4 (0.0, 0.7) |
| Montana 2 | *** | 137.5 (128.3, 147.3) | 5 (1, 32) | 933 |
stable
|
0.3 (-0.3, 0.9) |
| Rhode Island 2 | *** | 137.3 (128.4, 146.8) | 6 (1, 31) | 960 |
stable
|
0.4 (-0.2, 1.1) |
| Iowa 7 | *** | 137.2 (131.8, 142.8) | 7 (1, 26) | 2,674 |
stable
|
2.8 (-0.6, 6.3) |
| Connecticut 7 | *** | 136.9 (132.0, 141.9) | 8 (1, 24) | 3,236 |
rising
|
0.4 (0.1, 0.7) |
| New Hampshire 2 | *** | 136.3 (128.3, 144.6) | 9 (1, 31) | 1,229 |
rising
|
0.6 (0.1, 1.1) |
| Idaho 7 | *** | 135.9 (128.4, 143.7) | 10 (1, 31) | 1,326 |
rising
|
0.9 (0.3, 1.6) |
| Massachusetts 7 | *** | 135.0 (131.4, 138.6) | 11 (3, 25) | 5,943 |
stable
|
0.3 (0.0, 0.6) |
| New York 7 | *** | 134.6 (132.5, 136.8) | 12 (4, 21) | 16,668 |
rising
|
0.5 (0.2, 0.8) |
| Kansas 2 | *** | 133.3 (127.7, 139.2) | 13 (2, 31) | 2,289 |
stable
|
0.0 (-0.4, 0.5) |
| North Carolina 2 | *** | 133.3 (130.5, 136.3) | 14 (5, 26) | 8,738 |
rising
|
0.8 (0.6, 1.0) |
| Wisconsin 2 | *** | 133.1 (129.2, 137.1) | 15 (4, 28) | 4,858 |
rising
|
0.7 (0.5, 0.9) |
| Washington 4 | *** | 132.9 (129.4, 136.4) | 16 (4, 28) | 5,897 |
stable
|
0.2 (-0.3, 0.7) |
| Illinois 2 | *** | 132.0 (129.4, 134.7) | 17 (8, 27) | 10,332 |
rising
|
0.5 (0.3, 0.8) |
| Colorado 2 | *** | 132.0 (127.9, 136.2) | 18 (5, 30) | 4,191 |
stable
|
0.2 (-0.2, 0.5) |
| Missouri 2 | *** | 131.9 (128.1, 135.7) | 19 (6, 30) | 5,124 |
rising
|
0.5 (0.2, 0.8) |
| Pennsylvania 2 | *** | 131.2 (128.7, 133.8) | 20 (9, 28) | 11,213 |
rising
|
0.5 (0.3, 0.6) |
| Maryland 2 | *** | 131.1 (127.4, 135.0) | 21 (6, 30) | 4,958 |
stable
|
-0.1 (-0.7, 0.5) |
| Ohio 2 | *** | 130.1 (127.4, 132.8) | 22 (11, 30) | 9,830 |
rising
|
0.4 (0.1, 0.6) |
| South Carolina 2 | *** | 129.8 (125.8, 134.0) | 23 (8, 32) | 4,291 |
rising
|
0.5 (0.3, 0.7) |
| Nebraska 2 | *** | 129.6 (122.7, 136.7) | 24 (3, 38) | 1,446 |
stable
|
0.0 (-0.5, 0.5) |
| North Dakota 2 | *** | 129.3 (118.1, 141.3) | 25 (1, 47) | 543 |
stable
|
0.4 (-0.1, 1.0) |
| Louisiana 7 | *** | 128.7 (124.4, 133.1) | 26 (11, 33) | 3,630 |
rising
|
0.8 (0.5, 1.1) |
| Maine 2 | *** | 128.4 (120.9, 136.2) | 27 (4, 41) | 1,256 |
stable
|
-0.3 (-0.5, 0.0) |
| Georgia 7 | *** | 127.0 (124.1, 129.9) | 28 (19, 33) | 7,757 |
rising
|
0.5 (0.2, 0.8) |
| Kentucky 7 | *** | 125.7 (121.5, 130.1) | 29 (15, 38) | 3,551 |
rising
|
0.5 (0.3, 0.8) |
| Vermont 2 | *** | 125.1 (114.1, 137.0) | 30 (2, 50) | 539 |
stable
|
-0.1 (-0.5, 0.4) |
| South Dakota 2 | *** | 125.0 (115.0, 135.6) | 31 (3, 49) | 645 |
stable
|
0.1 (-1.0, 1.1) |
| Oklahoma 2 | *** | 124.1 (119.5, 128.8) | 32 (21, 42) | 2,953 |
rising
|
1.7 (0.4, 3.0) |
| California 7 | *** | 121.2 (119.8, 122.7) | 33 (29, 39) | 27,435 |
stable
|
-0.1 (-0.3, 0.2) |
| Virginia 2 | *** | 121.1 (118.1, 124.2) | 34 (28, 43) | 6,327 |
stable
|
0.2 (-0.1, 0.5) |
| Indiana 2 | *** | 119.5 (116.1, 123.0) | 35 (29, 45) | 4,945 |
rising
|
0.5 (0.2, 0.8) |
| Delaware 2 | *** | 119.3 (110.5, 128.6) | 36 (13, 51) | 765 |
stable
|
0.5 (-0.3, 1.2) |
| Oregon 2 | *** | 119.0 (114.7, 123.5) | 37 (29, 48) | 3,154 |
falling 
|
-0.6 (-0.9, -0.3) |
| Michigan 4 | *** | 119.0 # (116.2, 121.8) | 38 (31, 45) | 7,582 |
stable
|
-0.2 (-0.6, 0.1) |
| Mississippi 2 | *** | 118.9 (113.8, 124.1) | 39 (27, 49) | 2,204 |
rising
|
0.7 (0.3, 1.1) |
| Tennessee 2 | *** | 118.4 (115.1, 121.8) | 40 (31, 47) | 5,095 |
stable
|
0.3 (0.0, 0.7) |
| Nevada 2 | *** | 118.0 (112.8, 123.3) | 41 (29, 50) | 2,089 |
stable
|
-0.1 (-0.5, 0.3) |
| Alabama 2 | *** | 117.1 (113.2, 121.1) | 42 (31, 49) | 3,694 |
rising
|
0.4 (0.1, 0.7) |
| West Virginia 2 | *** | 115.3 (109.2, 121.7) | 43 (30, 51) | 1,474 |
stable
|
0.1 (-0.2, 0.5) |
| Arkansas 2 | *** | 114.6 (109.6, 119.7) | 44 (32, 51) | 2,163 |
rising
|
0.7 (0.1, 1.3) |
| Florida 2 | *** | 113.7 (111.9, 115.6) | 45 (40, 50) | 16,684 |
stable
|
0.2 (-0.1, 0.5) |
| New Mexico 7 | *** | 112.7 (106.7, 118.9) | 46 (32, 51) | 1,470 |
stable
|
0.1 (-0.3, 0.6) |
| Texas 2 | *** | 112.6 (110.9, 114.3) | 47 (42, 50) | 16,967 |
falling
|
-0.5 (-0.8, -0.2) |
| Utah 7 | *** | 112.3 (106.8, 118.1) | 48 (34, 51) | 1,582 |
stable
|
0.0 (-0.2, 0.2) |
| Alaska 2 | *** | 111.4 (100.2, 123.5) | 49 (24, 51) | 396 |
falling
|
-0.9 (-1.4, -0.4) |
| Arizona 2 | *** | 109.0 (105.8, 112.3) | 50 (44, 51) | 4,754 |
stable
|
-0.1 (-0.5, 0.4) |
| Wyoming 2 | *** | 107.6 (96.3, 119.9) | 51 (28, 51) | 363 |
stable
|
-0.5 (-1.2, 0.2) |
| Puerto Rico 2 | *** | 83.3 (79.5, 87.3) | N/A | 1,951 |
stable
|
-2.1 (-7.7, 3.9) |
Notes:
Created by statecancerprofiles.cancer.gov on 03/01/2021 5:59 am.
State Cancer Registries may provide more current or more local data.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.
† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The 1969-2017 US Population Data File is used for SEER and NPCR incidence rates.
‡ Incidence data come from different sources. Due to different years of data availability, most of the trends are AAPCs based on APCs but some are APCs calculated in SEER*Stat. Please refer to the source for each area for additional information.
Rates and trends are computed using different standards for malignancy. For more information see malignant.html.
^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.
*** No Healthy People 2020 Objective for this cancer.
Healthy People 2020 Objectives provided by the Centers for Disease Control and Prevention.
# Data do not include cases diagnosed in other states for those states in which the data exchange agreement specifically prohibits the release of data to third parties.
Source: SEER and NPCR data. For more specific information please see the table.
Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.
Data for United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.
Created by statecancerprofiles.cancer.gov on 03/01/2021 5:59 am.
State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.
† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The 1969-2017 US Population Data File is used for SEER and NPCR incidence rates.
‡ Incidence data come from different sources. Due to different years of data availability, most of the trends are AAPCs based on APCs but some are APCs calculated in SEER*Stat. Please refer to the source for each area for additional information.
Rates and trends are computed using different standards for malignancy. For more information see malignant.html.
^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.
*** No Healthy People 2020 Objective for this cancer.
Healthy People 2020 Objectives provided by the Centers for Disease Control and Prevention.
# Data do not include cases diagnosed in other states for those states in which the data exchange agreement specifically prohibits the release of data to third parties.
Source: SEER and NPCR data. For more specific information please see the table.
Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.
Data for United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.